VSV-G Peptide acetate

CAS No. ——

VSV-G Peptide acetate( —— )

Catalog No. M30128 CAS No. ——

VSV-G Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    VSV-G Peptide acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    VSV-G Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein.
  • Description
    VSV-G Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein.(In Vitro):VSV-G iswidely used for pseudotyping retroviral, lentiviral, and artificial viral vectors. VSV-G can be incorporated into Ad293 cells and is able to induce cell fusion, leading to the transfer of cytoplasmic protein.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    1339.52
  • Molecular Formula
    C57H94N16O19S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Liu X, et al. VSV-G Viral Envelope Glycoprotein Prepared from Pichia pastoris Enhances Transfection of DNA into Animal Cells. J Microbiol Biotechnol. 2017 Jun 28;27(6):1098-1105.
molnova catalog
related products
  • SARS-CoV-2 Mpro-IN-9

    SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.

  • Amcasertib

    A small-molecule inhibitor that inhibits Nanog and other CSC (cancer stem cells) pathways by targeting kinases.

  • P300/CBP-IN-3

    P300/CBP-IN-3 is an inhibitor of p300/CBP histone acetyltransferase.